Press release
Phototherapy for Psoriasis Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Drugs Market, Prevalence, Medication, Statistics, Therapies, Companies by DelveInsight
Phototherapy for Psoriasis Treatment Market
(Albnay, USA) DelveInsight's Phototherapy for Psoriasis Market Insights report proffers a detailed comprehension of the Phototherapy for Psoriasis market size by treatment, epidemiology, emerging therapies, market share of the individual therapies, current and forecasted Phototherapy for Psoriasis market size from 2019 to 2032 segmented into the 7MM (the USA, EU5 (Germany, France, Italy, Spain, and the UK), and Japan).
The Phototherapy for Psoriasis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Phototherapy for Psoriasis market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Phototherapy for Psoriasis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Phototherapy for Psoriasis market.
Request for sample report @ Phototherapy for Psoriasis Market Outlook [https://www.delveinsight.com/report-store/phototherapies-for-psoriasis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some of the salient features from the Phototherapy for Psoriasis Market Report:
* Phototherapy for Psoriasis market is expected to grow at a decent CAGR by 2032.
* DelveInsight analysts suggested that the Phototherapy for Psoriasis market size is expected to increase drastically owing to the launches of several potential emerging therapies during the study period.
* Key pharmaceutical Phototherapy for Psoriasis companies such as Phothera, Bristol Myers Squibb, Zerigo Health, Solarc Systems Inc, Dermalux and others are reported to bring a significant shift in the Phototherapy for Psoriasis.
* In 2022, the total diagnosed prevalent cases of psoriasis in the US were ~8 million, projected to increase during the forecast period (2023-2032).
* In October 2023, the FDA approved BIMZELX (bimekizumab-bkzx) for the treatment of moderate to severe psoriasis in adults who are candidates for systemic therapy or phototherapy. It is the first and only IL-17A and IL-17F inhibitor approved for the treatment of adults with moderate to severe plaque psoriasis.
* In September 2022, Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Sotyktu Trademark (deucravacitinib), a first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.1,2Sotyktu is not recommended for use in combination with other potent immunosuppressants.
For further information on the market impact by therapies, download the Phototherapy for Psoriasis sample @ Phototherapy for Psoriasis Therapeutic Scenario [https://www.delveinsight.com/sample-request/phototherapies-for-psoriasis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Phototherapy for Psoriasis Overview
Phototherapy is a widely used treatment for psoriasis, leveraging controlled exposure to ultraviolet (UV) light to reduce inflammation and slow the excessive growth of skin cells. The primary types of phototherapy include narrowband UVB (NB-UVB), broadband UVB, psoralen plus UVA (PUVA), and targeted laser treatments such as the excimer laser. These therapies are particularly beneficial for moderate to severe psoriasis cases that do not respond well to topical treatments.
The demand for phototherapies is driven by their cost-effectiveness, non-invasive nature, and efficacy in managing psoriasis symptoms. Advancements in technology have led to the development of home-based phototherapy devices, improving accessibility for patients. Additionally, increased awareness and favorable reimbursement policies in some regions have further boosted market adoption.
However, market growth is hindered by safety concerns associated with long-term UV exposure, which increases the risk of skin cancer. The availability of biologic and systemic treatments, which offer targeted mechanisms with fewer side effects, also poses competition. Furthermore, high equipment costs and limited access to treatment centers, especially in developing regions, remain significant challenges.
Despite these barriers, the phototherapy market is expected to grow due to ongoing research and technological advancements, ensuring safer and more efficient treatment options for psoriasis patients.
Phototherapy for Psoriasis Epidemiology Segmentation
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Psoriasis Epidemiology Segmentation:
The Psoriasis epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by:
* Diagnosed Prevalence of Psoriasis in Adults
* Diagnosed Prevalence of Psoriasis in Paediatrics
* Diagnosed Prevalence of Psoriasis by Types
* Diagnosed Prevalence of Psoriasis by Location
* Diagnosed Prevalence of Psoriasis by Severity
Keen to learn how Phototherapy for Psoriasis Epidemiological Trends are going to appear in 2032 for the 7MM, Download @ Phototherapy for Psoriasis Prevalence [https://www.delveinsight.com/report-store/phototherapies-for-psoriasis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Phototherapy for Psoriasis Market Outlook
The Phototherapies for Psoriasis Market is driven by several key factors, primarily the increasing global prevalence of psoriasis, which is fueling demand for effective treatment options like phototherapy. Technological advancements, including excimer laser therapy and targeted UVB treatments, have enhanced efficacy and patient convenience, further promoting market expansion. Additionally, rising awareness and improved diagnostic rates have led to higher patient adoption of phototherapy. Favorable reimbursement policies in some regions are improving accessibility, while the cost-effectiveness and minimally invasive nature of phototherapy make it an attractive alternative to biologics and systemic treatments. Moreover, the rising demand for home-based phototherapy devices is expanding market penetration, particularly in areas with limited healthcare access. However, several barriers hinder market growth, including safety concerns related to long-term UV exposure, which increases the risk of skin cancer. The availability of alternative treatments, such as biologics and systemic therapies with higher efficacy, poses significant competition. Furthermore, the high initial cost of phototherapy equipment, restricted access to specialized treatment centers in rural areas, and stringent regulatory requirements for device approval limit widespread adoption. Despite these challenges, continuous research and development efforts are expected to drive innovation and improve the safety and effectiveness of phototherapy solutions for psoriasis management.
Discover more about therapy set to grab substantial Phototherapy for Psoriasis market share @ Phototherapy for Psoriasis Treatment Market [https://www.delveinsight.com/sample-request/phototherapies-for-psoriasis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Scope of the Phototherapy for Psoriasis Market Report
* Study Period: 2019-32
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Phototherapy for Psoriasis Companies: Phothera, Bristol Myers Squibb, Zerigo Health, Solarc Systems Inc, Dermalux and others
* Phototherapy for Psoriasis Therapeutic Assessment: Phototherapy for Psoriasis current marketed and emerging therapies
* Phototherapy for Psoriasis Dynamics: Phototherapy for Psoriasis drivers and barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Unmet Needs, KOL's views, Analyst's views, Phototherapy for Psoriasis Access and Reimbursement
Request for sample report @ https://www.delveinsight.com/sample-request/phototherapies-for-psoriasis-market [https://www.delveinsight.com/sample-request/phototherapies-for-psoriasis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Table of Contents
1. Key Insights
2. Report Introduction
3. Phototherapy for Psoriasis Market Overview at a Glance
4. Executive Summary of Phototherapy for Psoriasis
5. Phototherapy for Psoriasis Epidemiology and Market Methodology
6. Phototherapy for Psoriasis: Disease Background and Overview
7. Diagnosis of Phototherapy for Psoriasis
8. Phototherapy for Psoriasis Treatment
9. Conclusion for Phototherapy for Psoriasis
10. Phototherapy for Psoriasis Epidemiology and Patient Population
11. Phototherapy for Psoriasis Patient Journey
12. Key Endpoints in Phototherapy for Psoriasis Clinical Trials
13. Phototherapy for Psoriasis Marketed Therapies
14. Phototherapy for Psoriasis Emerging Therapies
15. Phototherapy for Psoriasis: 7 Major Market Analysis
16. Market Access and Reimbursement
17. KOL Views
18. Phototherapy for Psoriasis Market Drivers
19. Phototherapy for Psoriasis Market Barriers
20. Phototherapy for Psoriasis SWOT Analysis
21. Phototherapy for Psoriasis Unmet Needs
22. Appendix
23. DelveInsight Capabilities
24. Disclaimer
25. About DelveInsight
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=phototherapy-for-psoriasis-treatment-market-2032-clinical-trials-ema-pdma-fda-approvals-drugs-market-prevalence-medication-statistics-therapies-companies-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Phototherapy for Psoriasis Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Drugs Market, Prevalence, Medication, Statistics, Therapies, Companies by DelveInsight here
News-ID: 3915235 • Views: …
More Releases from ABNewswire
Denver's Best Appliance Repair Responds to Rising Demand for Emergency Appliance …
Denver's Best Appliance Repair expands emergency services across the Denver metro with same-day repairs, 7-day availability, 5-year parts warranty, and professional licensed technicians serving residential and commercial clients.
Household appliance failures don't follow a schedule. When a refrigerator stops cooling in the middle of summer or a washing machine floods a basement on a Sunday evening, families need immediate help. Denver's Best Appliance Repair has responded to this growing need by…
Oak Hill Clinic Reaches 30,000 Client Milestone with Results-Driven Deep Tissue …
Deep Relief in Oak Hill, Austin, has served 30,000 clients through specialized massage, chiropractic, and acupuncture care. The clinic accepts insurance and focuses on results-driven treatments for pain relief.
Deep Relief, an Oak Hill-based wellness clinic, has achieved a significant milestone by serving more than 30,000 clients seeking Relief from chronic pain, muscle tension, and mobility issues. The clinic's success stems from its commitment to advanced, results-focused bodywork that goes beyond…
Vertex Fleet Expands Nationwide Network to Combat Growing Trailer Drop Yard Shor …
Vertex Fleet announces major expansion of secure parking facilities nationwide, addressing the critical shortage of commercial vehicle storage with 15+ new locations featuring 24/7 security and technology-driven access.
The freight and logistics industry faces a mounting crisis as demand for secure parking spaces continues to outpace supply across the United States. Vertex Fleet [https://www.vertexfleet.com/], a leading provider of industrial outdoor storage solutions, has announced significant expansion plans to address this critical…
HVAC in Denver Sees Service Enhancement as Denver's Best Heating and AC Repair L …
Denver's Best Heating and AC Repair expands 24/7 emergency services across 23 metro cities, offering A+ rated heating, cooling, and commercial HVAC solutions with rapid response times and multi-brand expertise.
Denver's Best Heating and AC Repair [https://www.denversbestheatingandacrepair.com/]has expanded its service capabilities to meet growing demand for reliable heating and cooling solutions across the Denver Metro area. The A+ rated contractor now provides 24/7 emergency response services to 23 cities, addressing critical…
More Releases for Psoriasis
Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual…
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
